HKU Team Finds Way To Treat Covid With Ulcer Drug
"); jQuery("#212 h3").html("
"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1554222_1_20201012174849.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1554222-20201012.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1554222-20201012.htm', 'DCS.dcsqry', '' ); } } }); }); });
2020-10-12 HKT 12:48
Share this story
Researchers at the University of Hong Kong said on Monday that they have found that a way to tackle the novel coronavirus with a drug that is commonly used to treat stomach ulcers.
They said experiments in the laboratory showed that the drug, ranitidine bismuth citrate (RBC), which contains a metal called bismuth, can be used to reduce viral loads in coronavirus-infected cells by over 1,000-fold.
Dr Runming Wang from the university’s Department of Chemistry said the drug is also cheaper and safer than Remdesivir, which is currently used to treat Covid-19.
He said the drug works by targeting a protein in the virus and preventing the virus from replicating.
“As the process of developing an effective vaccine is still ongoing, another approach for preventing and treatment of the disease is to identify anti-Covid-19 agents from existing drugs to repurpose their uses,” he said.
Wang said the drug can be stored at room temperature and without any special requirements.
The team said it had applied for a patent in the US.
A16z Crypto Opens First Office In Seoul To Expand In Asia
a16z crypto, the crypto-focused arm of Andreessen Horowitz, has announced its expansion into Asia with the opening of i... Read more
Trio AI And AbbyPay Partner To Integrate AI Into Payment Processing
Trio AI, a Hong Kong-based AI infrastructure service provider, has signed a MouU with AbbyPay, a POS-free digital payme... Read more
Modernising Bank Payments: How Banks Can Win In Merchant Acquiring
Banks have been the backbone of merchant acquiring. Their regulatory strength, trusted brands, and long-standing mercha... Read more
KPay Enables Tap To Pay On IPhone For Hong Kong Merchants
KPay now allows its Hong Kong merchants to accept in-person contactless payments using Tap to Pay on iPhone. The featur... Read more
HashKey Group IPO Targets Up To HK1.67 Billion In Hong Kong Listing
Licensed crypto exchange HashKey Group is intending to raise as much as HK$1.67 billion in its Hong Kong initial public... Read more
Endowus Launches Income Enhanced Portfolio For Professional Investors
Endowus, an independent wealth advisor and investment platform in Asia, has launched its Income Enhanced Portfolio, ava... Read more